Jeffrey A Kahn

Dr. Jeffrey A. Kahn has led transformative projects in the field of liver transplantation and hepatology, making significant contributions to the understanding and treatment of liver diseases. As a Professor of Clinical Medicine and the Medical Director of the USC Liver Transplant Program at the School of Medicine, University of Southern California, he has been at the forefront of pioneering research and clinical advancements. His expertise in liver transplantation, hepatocellular carcinoma, and viral hepatitis has positioned him as a leader in these specialized areas. Dr. Kahn's scholarly work includes numerous abstracts and peer-reviewed articles, reflecting his commitment to advancing medical knowledge and improving patient outcomes. His research interests are deeply rooted in liver transplantation, hepatocellular carcinoma, and viral hepatitis, where he continues to explore innovative approaches and therapies. His dedication to research is matched by his passion for teaching, as he is a distinguished lecturer who has inspired many in the medical community. Throughout his career, Dr. Kahn has been recognized for his exceptional contributions to medicine. Among his accolades is the prestigious Alpha Omega Alpha award, which he received in 1990, highlighting his longstanding commitment to excellence in the field. His work not only impacts the academic community but also translates into tangible benefits for patients dealing with complex liver conditions. In addition to his research and teaching roles, Dr. Kahn is actively involved in clinical practice, where he applies his extensive knowledge to provide top-tier care for patients undergoing liver transplantation. His leadership at the USC Liver Transplant Program ensures that patients receive comprehensive and compassionate care, guided by the latest research and clinical practices. Dr. Kahn's dedication to his field continues to drive advancements in hepatology and transplantation, making a lasting impact on both his patients and the broader medical community.